Biomarkers In Ovarian Cancer Immunotherapy Clinical Trials Lecture Presentation: 2016 Biennial Meeting Jalid Sehouli | Germany Ovarian Cancer Clinical Trials Lecture Presentation: 2016 Biennial Meeting Ignace Vergote | Belgium New Wave of Targeted Therapy Lecture Presentation: 2014 Biennial Meeting Jae-Weon Kim |South Korea The Role Of The Fallopian Tube In Pelvic Epithelial Cancers: Translational Discoveries Lecture Presentation: 2014 Biennial Meeting Ronny Drapkin | USA Prospective Pilot Study Of Patient Reported Outcomes After Extensive Surgery For Ovarian Cancer Lecture Presentation: 2014 Biennial Meeting Sudha Sundar | United Kingdom

The Diagnostic Value Of Adding HE4 To CA12S For Women Investigated For Ovarian Cancer In Primary Care: A Prospective Pilot Study Lecture Presentation: 2014 Biennial Meeting Nithya Ratnavelu | United Kingdom

New Issues in Pathology of Clear Cell Carcinoma or Hereditary Cancer Syndromes Other than BRCA in Ovarian Cancer Lecture Presentation: 2018 Biennial Meeting Takako Kiyokawa | Japan Population Prevalence Of UK Ashkenazi BRCA-Mutations, Performance Of And Estimated Time-To, Family-History Based Identification Of All BRCA Carriers Lecture Presentation: 2014 Biennial Meeting Ian Jacobs | United Kingdom

Pathology of HGSC; What’s New Lecture Presentation: 2018 Biennial Meeting Naveena Singh | United Kingdom Fallopian Tube As The Cause Of BRCA-Associated Ovarian Cancer Lecture Presentation: 2014 Biennial Meeting Ronny Drapkin | USA Hereditary Gene Panels In The Assessment Of The Ovarian Cancer Patient Lecture Presentation: 2014 Biennial Meeting Noah Kauff | USA Identification Of Six Novel, Common Variant Genetic Susceptibility Loci For Invasive Epithelial Ovarian Cancer Lecture Presentation: 2014 Biennial Meeting Andrew Berchuk | USA

Chromosomal Instability In Cell-Free Dna As A Highly Specific Biomarker For Ovarian Cancer Detection Lecture Presentation: 2016 Biennial Meeting Adriaan Vanderstichele| Belgium Ovarian Cancer Prevention, A Promising Strategy Lecture Presentation: 2016 Biennial Meeting Uzi Beller | Israel Strategies in Prevention Lecture Presentation: 2016 Biennial Meeting Jessica McAlpine | Canada

Population Screening for Hereditary Gynecological Cancer Lecture Presentation: 2018 Biennial Meeting Ephrat Levi-Lahad | Israel BRCANESS, Clinical Implications for Patients and Carriers  Lecture Presentation: 2018 Biennial Meeting Douglas Levine | USA Can We Stratify Ovarian Cancer Patients?  Lecture Presentation: 2018 Biennial Meeting Michael Birrer | USA The Effect of Asprin, Statins, Metformin, and Metabolic Co-morbidities on the Prognosis of Patients with Ovarian Cancer Education Exchange: 2016 Biennial Meeting Ayelet Shai | USA

Familial BRCA Consumer Perspective Karen Livingston | Australia Lecture Presentation: 2014 Biennial Meeting

Hope, Quality of Life, and Benefit from Treatment in Women Having Chemotherapy for Recurrent Ovarian Cancer Lecture Presentation: 2018 Biennial Meeting Don Dizon | USA Chemotherapy and Targeted Therapy in Recurrent Ovarian Cancer Lecture Presentation: 2018 Biennial Meeting Alexander Olawaiye | USA Clear Cell Carcinoma Lecture Presentation: 2018 Biennial Meeting David Tan | Singapore Low-Grade Serous Carcinoma Lecture Presentation: 2018 Biennial Meeting David Gershenson | USA Elucidating the First Line Ovarian Cancer Landscape: How Will This Affect Relapse Approach? Lecture Presentation: 2018 Biennial Meeting Ana Oaknin | Spain Targeted Therapy for First Line Advanced Ovarian Cancer: Flying with Biologics Lecture Presentation: 2018 Biennial Meeting Robert Coleman | USA Tailoring the Best First Line Treatment in Advanced Ovarian Cancer: Is There Still a Role for Intraperioneal or Dose-dense Chemotherapy? Lecture Presentation: 2018 Biennial Meeting Shannon Westin | USA Management of HGSC Lecture Presentation: 2018 Biennial Meeting Fernando Maluf | Brazil Management of Clear Cell Carcinoma – Role of Adjuvant Treatment; Management of Recurrence Lecture Presentation: 2018 Biennial Meeting David Tan | Singapore Management of Low-Grade Serous Carcinoma Lecture Presentation: 2018 Biennial Meeting David Gershenson | USA Topotecan (T) ± Sorafenib (S) For Platinum-Resistant Ovarian Cancer (Proc): Results Of Double-Blind Placebo-Controlled Randomized Noggo – Ago Intergroup Trial Lecture Presentation: 2016 Biennial Meeting Jalid Sehouli | Germany A Randomized Placebo Controlled

Pathology of HGSC; What’s New Lecture Presentation: 2018 Biennial Meeting Naveena Singh | United Kingdom New Issues in Pathology of Clear Cell Carcinoma or Hereditary Cancer Syndromes Other than BRCA in Ovarian Cancer Lecture Presentation: 2018 Biennial Meeting Takako Kiyokawa | Japan Synchronous Endometrial and Ovarian Endometrioid Cancer with Endometriosis Lecture Presentation: 2018 Biennial Meeting Robert Soslow | USA Synchronous Endometrial and Ovarian Endometrioid Cancer with Endometriosis Lecture Presentation: 2018 Biennial Meeting Robert Soslow | USA Ovarian Cancer Tumor Board Lecture Presentation: 2016 Biennial Meeting Keiichi Fujiwara | Japan Optimal Treatment Of Ovarian Cancer In The Frontline Setting Lecture Presentation: 2016 Biennial Meeting Tom Herzog | USA Case 4: Mucinous Adenocarcinoma Of The Ovary Figo Iiic Adjuvant Treatment Lecture Presentation: 2016 Biennial Meeting Stephan Polterauer | Austria Case 4: Pathology, Biologic Behavior, Differential Diagnosis Of Mucinous Ovarian Tumors Lecture Presentation: 2016 Biennial Meeting Jaime Prat | Spain Case 1: Early Stage Ovarian Cancer Lecture Presentation: 2014 Biennial Meeting Robert Coleman | USA When Genitourinary Injuries Occur: A Consulting Urologists Perspective Lecture Presentation: 2014 Biennial Meeting Philip Dundee | Australia